Skip to Content

54 157 (Montelukast sodium 10 mg (base))

Pill imprint 54 157 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of hay fever; bronchospasm prophylaxis; asthma, maintenance; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Montelukast sodium 10 mg (base) 54 157
Montelukast sodium 10 mg (base) 54 157
Montelukast sodium
54 157
10 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Roxane Laboratories, Inc.
National Drug Code (NDC):
Inactive Ingredients:
ferric oxide red
ferric oxide yellow
polyethylene glycol 3350
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.